According to a recent LinkedIn post from Infinitus Systems, the company is introducing Infinitus Studio, described as a no-code AI agent builder tailored for healthcare workflows. The post indicates that the platform is designed to let organizations design, test, and deploy AI agents using plain language while integrating with existing operational systems.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights claims that agents built with Studio can be deployed 90% faster and achieve 40% higher accuracy, with an emphasis on safety, compliance, and reliability requirements in healthcare. If realized at scale, these capabilities could lower implementation friction for healthcare customers, potentially accelerating adoption, expanding Infinitus Systems’ addressable market, and strengthening its competitive positioning in healthcare-focused AI infrastructure.
As shared in the post, Infinitus Systems is also promoting an early-access program via a sign-up link, suggesting the product is in a controlled rollout phase rather than full general availability. For investors, this may indicate an inflection point in the company’s product roadmap, with near-term focus on validating performance claims, securing reference customers, and converting early adopters into recurring revenue streams in a highly regulated, high-value vertical.